Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria

O. Gajovic, P. Canovic, Z. Todorovic, L. Nesic, Z. Mijailovic, Z. Lazic (Kragujevac, Serbia And Montenegro)

Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Session: Diagnostic markers and therapy in hospital-acquired pneumonia
Session type: Thematic Poster Session
Number: 2409
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Gajovic, P. Canovic, Z. Todorovic, L. Nesic, Z. Mijailovic, Z. Lazic (Kragujevac, Serbia And Montenegro). Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria. Eur Respir J 2007; 30: Suppl. 51, 2409

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
Source: Eur Respir J 2015; 45: 1353-1363
Year: 2015



Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004

The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Epidemiology of community- and hospital-acquired pneumonia
Source: Annual Congress 2003 - PG11 - Pneumonia epidemiology and diagnosis
Year: 2003

Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009



The lung bacterial microbiome in community-acquired and nosocomial pneumonia
Source: Eur Respir Monogr 2019; 83: 188-194
Year: 2019


Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Multidrug-resistant bacteria in community-acquired pneumonia
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017


Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007



VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011


Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002



Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007



Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Source: Eur Respir J 2008; 31: 625-632
Year: 2008